Anti-FANCE [L5-P1E6*G5]

As part of the Fanconi anemia (FA) complex functions in DNA cross-links repair. Required for the nuclear accumulation of FANCC and provides a critical bridge between the FA complex and FANCD2.

Contributors

Inventor Institute
Ayham Alnabulsi Vertebrate Antibodies Limited
Cat. #: 152688
Tool sub type: Primary antibody
Unit size: 100 ug
Research Fields: Genetics
Application: ELISA ; IHC ; WB
Target: Fanconi Anemia, Complementation Group E (FANCE)
Reactivity: Human
Clone: L5-P1E6*G5
Host: Mouse
Class: Monoclonal
Alternate name: Fanconi Anemia Complementation Group E; FACE; FAE
Product description: As part of the Fanconi anemia (FA) complex functions in DNA cross-links repair. Required for the nuclear accumulation of FANCC and provides a critical bridge between the FA complex and FANCD2.
Conjugation: Unconjugated
Isotype: IgG1 kappa
Immunogen: Ovalbumin-conjugated synthetic peptide – KAALKHLGP
Myeloma used: P3X63Ag8.653
Target background: As part of the Fanconi anemia (FA) complex functions in DNA cross-links repair. Required for the nuclear accumulation of FANCC and provides a critical bridge between the FA complex and FANCD2.
Format: Liquid
Concentration: 0.9-1.1 mg/ml
Storage buffer: PBS with 0.02% azide
Storage conditions: -15° C to -25° C
Shipping conditions: Dry ice

Images

View Gallery
A western blot analysis using Jurkat cell lysates and Anti-FANCE clone L5-P1E6*G5

Related Tools for Antibodies

Cat. # Tool Name
151030 Anti-Progesterone [11P14] Key Info View Tool
151021 Anti-CyclinB1 [V152] Key Info View Tool
151022 Anti-IL12 [1-1A4] Key Info View Tool
151024 Anti-Hairy [1/24] Key Info View Tool
151018 Anti-Mos [R38.1] Key Info View Tool

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.